Overview
Status
Active
Registry date
2017-12-14
Share capital
5,400.00 PLN
Registered address
Kielce, Poland
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Total Assets
1.36k
0.0% vs 2024
Revenue history
Financial insight
- The statement flags a going concern risk. spółka jest w likwidacji
Filing timeliness
6 of 6 financial statements were filed late (the longest delay 566 days for 2021).
- 202514/08/2026
- 202414/08/2026
- 202318/07/2025
- 202201/02/2024
- 202101/02/2024
- 202026/10/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Adam Dąbrowski – Liquidator
Hubert Adrian Ziętala – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Adam Dąbrowskiage 40 | 18 | $486.22 | 33.3333% |
Tomasz Jarosław Kossakage 45 | 18 | $486.22 | 33.3333% |
Hubert Adrian Ziętalaage 40 | 18 | $486.22 | 33.3333% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Oct 21, 2020 | Liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Adamed PharmaS.A. | $541,927,181.76 | adamed.com.pl | ||
| Aflofarm Farmacja Polskasp. z o.o. | $302,019,142.07 | aflofarm.pl | ||
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Celon PharmaS.A. | $52,550,739.16 | celonpharma.com | ||
| Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Eximsp. z o.o. | $1,592,037.83 | sulphur.com.pl | ||
| Biomarsp. z o.o. | $909,113.28 | biomar.pl | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-04 | Address change (Ul. Stefana Okrzei 64/3, 25-526, Kielce → Kielce) | |
| 2020-11-27 | Name change (Kossaklab → Kossaklab Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2020-07-31 | Liquidation opened | |
| 2018-09-04 | Address change (Ul. Zagórska 20/39, 25-355, Kielce → Ul. Stefana Okrzei 64/3, 25-526, Kielce) | |
| 2017-12-14 | Entered in the register |
FAQ
The main business activity of Kossaklab focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on December 14, 2017.
The headquarters is located at: Kielce.
The share capital of the company is PLN 5,400 (approx. $1,459).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Yes, in 2025 the company was profitable, achieving a net profit of USD 0.
Last updated: 2026-08-14